Evidence map›Paper›PMID 36802431›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2023

A synthetic porphyrin as an effective dual antidote against carbon monoxide and cyanide poisoning.

Qiyue Mao, Xuansu Zhao, Akiko Kiriyama, Shigeru Negi, Yasutaka Fukuda, Hideki Yoshioka, Akira T Kawaguchi, Roberto Motterlini, Roberta Foresti, Hiroaki Kitagishi

Open access · hybridAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Artificial porphyrin molecules clean up carbon monoxide and cyanide.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 2 countries.

Qiyue MaoDepartment of Molecular Chemistry and Biochemistry, Faculty of Science and Engineering, Doshisha University, Kyotanabe, Kyoto 610-0321, Japan.
Xuansu ZhaoDepartment of Fire Engineering, Building Research Institute, Tsukuba, Ibaraki 305-0802, Japan.ORCID 0000-0002-0997-6750
Akiko KiriyamaFaculty of Pharmaceutical Science, Doshisha Women's College of Liberal Arts, Kyotanabe, Kyoto 610-0395, Japan.ORCID 0000-0001-7772-9367
Shigeru NegiFaculty of Pharmaceutical Science, Doshisha Women's College of Liberal Arts, Kyotanabe, Kyoto 610-0395, Japan.
Yasutaka FukudaTsukuba Building Research and Testing Laboratory, Center for Better Living, Tsukuba, Ibaraki 305-0802, Japan.
Hideki YoshiokaDepartment of Architecture, Graduate School of Engineering, The University of Tokyo, Hongo, Bunkyo-ku, Tokyo 113-8656, Japan.
Akira T KawaguchiDepartment of Innovative Medical Science Tokai University, Isehara, Kanagawa 259-1193, Japan.ORCID 0000-0003-0893-7888
Roberto MotterliniUniversity Paris Est Creteil, INSERM, Institut Mondor de Recherche Biomédicale (IMRB), Creteil F-94010, France.ORCID 0000-0003-2684-2612
Roberta ForestiUniversity Paris Est Creteil, INSERM, Institut Mondor de Recherche Biomédicale (IMRB), Creteil F-94010, France.ORCID 0000-0002-0836-7937
Hiroaki KitagishiDepartment of Molecular Chemistry and Biochemistry, Faculty of Science and Engineering, Doshisha University, Kyotanabe, Kyoto 610-0321, Japan.ORCID 0000-0003-4682-7217
Building Research Institute · JPDoshisha University · JPDoshisha Women's College of Liberal Arts · JPInserm · FRThe University of Tokyo · JPTokai University · JP

Funding

Japan Agency for Medical Research and Development (AMED) 22ym0126814j0001Japan Society for the Promotion of Science London (JSPS) JP21K20543MEXT | Japan Society for the Promotion of Science (JSPS) JP20H02871Uehara Memorial Foundation (UMF) 202120130
6 · The paper itself

Abstract

Simultaneous poisoning by carbon monoxide (CO) and hydrogen cyanide is the major cause of mortality in fire gas accidents. Here, we report on the invention of an injectable antidote against CO and cyanide (CN

Indexed as

Carbon MonoxidePorphyrinsAnimalsAntidotesCyanidesFerric CompoundsFerrous CompoundsIronMiceOxygenRatsAntidotesCarbon MonoxideCyanidesFerric CompoundsFerrous CompoundsIronOxygenPorphyrinscarbon monoxidecyanidefire gasporphyrinsupramolecular chemistry

Identifiers

PMID36802431
PMCPMC9992825
OpenAlexW4321440672

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.